Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Original Research

Published on 31 Aug 2023

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study

in Gastrointestinal and Hepatic Pharmacology

Fang Cheng
Xian-Gao Jiang
Shi-Lin Zheng
Te Wu
Qiang Zhang
Xin-Chun Ye
Saiduo Liu
Ji-Chan Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1171353

2,353 views
5 citations

Review

Published on 31 Aug 2023

Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects

in Gastrointestinal and Hepatic Pharmacology

Dan Shan
Siyu Dai
Qian Chen
Yupei Xie
Yayi Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218432

6,588 views
6 citations

Review

Published on 30 Aug 2023

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women

in Gastrointestinal and Hepatic Pharmacology

ChenLu Zhao
JunHao Shi
DongFang Shang
Min Guo
Cheng Zhou
WenXia Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237845

4,156 views
3 citations

Review

Published on 29 Aug 2023

Therapeutic potential of sulforaphane in liver diseases: a review

in Gastrointestinal and Hepatic Pharmacology

Liang Yan
Yachun Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256029

10,090 views
10 citations

Original Research

Published on 28 Aug 2023

Inadequate gastric preparation and its associated factors for magnetically controlled capsule endoscopy

in Gastrointestinal and Hepatic Pharmacology

Qing-Zhou Kong
Cheng Peng
Zhen Li
Bao-Ling Tian
Yue-Yue Li
Fei-Xue Chen
Xiu-Li Zuo
Yan-Qing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184754

2,038 views
2 citations

Systematic Review

Published on 25 Aug 2023

Long-term proton pump inhibitors use and its association with premalignant gastric lesions: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Zeyi Zheng
Ziyu Lu
Yani Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244400

5,843 views
4 citations

Study Protocol

Published on 24 Aug 2023

Effect of anti-obesity agent HSG4112 on overweight and obese patients following 12 weeks of oral treatment: a study protocol for a randomised, double-blind, placebo-controlled, parallel-group, phase 2a clinical trial

in Gastrointestinal and Hepatic Pharmacology

Kyungha Min
Bumjo Oh
Hye Yeon Koo
Yang-Hyun Kim
Ji-Won Lee
Sangsub Lee
Youngah Kim
Hyuktae Kwon

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1177539

3,235 views

Original Research

Published on 24 Aug 2023

YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

in Gastrointestinal and Hepatic Pharmacology

Zhan Jing-Lun
Chai Shuang
Zhao Li-Mei
Liu Xiao-Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205062

2,211 views
5 citations

Review

Published on 23 Aug 2023

The role of gut microbiota and drug interactions in the development of colorectal cancer

in Gastrointestinal and Hepatic Pharmacology

Jinna Wu
Cong Xia
Can Liu
Qianshi Zhang
Chenglai Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265136

3,824 views
4 citations

Original Research

Published on 17 Aug 2023

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib

in Gastrointestinal and Hepatic Pharmacology

Yan Wu
Meihao Wei
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200254

7,132 views
14 citations

Original Research

Published on 17 Aug 2023

A novel role of the splenic volume in Crohn’s disease: evaluating the efficacy of infliximab

in Gastrointestinal and Hepatic Pharmacology

Xuan Shi
Jia-Hui Wang
Sheng-Xiang Rao
Tao-Tao Liu
Hao Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1246657

2,414 views
3 citations

Review

Published on 17 Aug 2023

Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma

in Gastrointestinal and Hepatic Pharmacology

Yi Yuan
Dailin Wu
Jing Li
Dan Huang
Yan Zhao
Tianqi Gao
Zhenjie Zhuang
Ying Cui
Da-Yong Zheng
Ying Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217400

8,212 views
11 citations

Original Research

Published on 15 Aug 2023

Sinapic acid alleviates inflammatory bowel disease (IBD) through localization of tight junction proteins by direct binding to TAK1 and improves intestinal microbiota

in Gastrointestinal and Hepatic Pharmacology

Sehyeon Jang
San Kim
Bo Ram So
Younghoon Kim
Chang-Kil Kim
Jeong Jae Lee
Sung Keun Jung

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217111

4,249 views
10 citations

Review

Published on 08 Aug 2023

Progress of research on molecular targeted therapies for colorectal cancer

in Gastrointestinal and Hepatic Pharmacology

Shilin Huang
Jiazhou Ye
Xing Gao
Xi Huang
Julu Huang
Lu Lu
Cheng Lu
Yongqiang Li
Min Luo
Mingzhi Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1160949

4,848 views
9 citations

Original Research

Published on 08 Aug 2023

The immune and metabolic treatment approach of using testosterone on mice models of liver injury

in Gastrointestinal and Hepatic Pharmacology

Johnny Amer
Ahmad Salhab
Hadeel Snobar
Yazan Alhabil

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219709

3,013 views
2 citations

Editorial

Published on 07 Aug 2023

Editorial: Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals

in Gastrointestinal and Hepatic Pharmacology

Nehal M. Ramadan
Priscila O. Barbosa
Nada F. Abo El-Magd
Salma M. Eraky
Mohammed M. H. Al-Gayyar

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1266168

1,459 views